Heide Ford Lab
@heidefordlab.bsky.social
510 followers 650 following 21 posts
Professor and Chair, Department of Pharmacology University of Colorado Anschutz Medical Campus Cancer biologist, metastasis researcher interested in tumor cell plasticity Colorado and outdoor enthusiast 🏔️🏔️☀️
Posts Media Videos Starter Packs
Sharing this new review written by two talented trainees from the Ford lab, Sheera Rosenbaum and Kaiah Fields. @kaiahfields.bsky.social
The ability of #cancer and immune cells to change their phenotype contributes to tumor progression and therapy resistance. @heidefordlab.bsky.social explores the mutual plasticity of cells in the tumor microenvironment and why this matters for the development of therapies 🧪 plos.io/4774Y7a
Masters of adaptation: How cancer and immune cell plasticity mediates tumor progression
The ability of cancer cells and immune cells cell to dynamically change their phenotype contributes to tumor progression and therapy resistance. This Essay explores the mutual plasticity of various ce...
plos.io
So impressed by our new faculty members Justin O’Hare and Debo Sardar for being 2 of only 12 nationally who received the Klingenstein award this year! @debo-astrocyte.bsky.social @justinkohare.bsky.social
Congratulations to Debosmita Sardar, PhD, and Justin O’Hare, PhD, Assistant Professors in the Department of Pharmacology, who have received Klingenstein Fellowships in Neuroscience, one of the nation’s most prestigious awards for early career scientists. Learn More: bit.ly/44y8nJD
Debosmita Sardar, PhD, and Justin O'Hare, PhD.
Excited to share a new study from the Ford lab: EYA3 regulation of NF-κB and CCL2 suppresses cytotoxic NK cells in the premetastatic niche to promote TNBC metastasis | Science Advances www.science.org/doi/10.1126/...
Congratulations to Sheera Rosenbaum and Connor Hughes, as well as all co-authors!
EYA3 regulation of NF-κB and CCL2 suppresses cytotoxic NK cells in the premetastatic niche to promote TNBC metastasis
EYA3 promotes evasion of cytotoxic NK cells to enable metastasis, highlighting a therapeutic target in metastatic breast cancer.
www.science.org
So fortunate to work with all these amazing women in our department!
As Women's History Month comes to a close, we celebrate the incredible women on our primary faculty and their invaluable contributions to the pharmacology field. Their dedication to research, mentorship and innovation continues to shape the future of science and medicine. #WomeninSTEM #CUAnschutz
So proud of Ford lab members who have recently defended their theses (Connor Purdy and Art Wolin) and matched into the Duke internal medicine residency (Connor Hughes, MSTP). It’s been a busy couple of months for the lab, but nothing is more special than watching the success of your trainees!
Would love to be added to this starter pack! Thank you!
Reposted by Heide Ford Lab
Welcome to the faculty @alebrambati.bsky.social! Read more about Ale’s background and research areas below. 🧬
Would love to be added to this group if there is room! Thx
Would love to get on this one too- if there is space to add me! Thanks!
Interested in doing your postdoc with the Department of Pharmacology at @CUAnschutz? Join us for our Postdoctoral Education & Knowledge Summit with @cuanschutz_dpb and the Department of Biochemistry & Molecular Genetics!

Applications close December 1st. bit.ly/CU-PEAKS
CU PEAKS
bit.ly
Excited to share my first real post on Bluesky: New preprint from the Ford lab on an eya3/nfkb/ccl2 axis and the pre-metastatic niche in breast cancer. www.biorxiv.org/content/bior...
www.biorxiv.org
Would love to join this if there is room! @heidefordlab.bsky.social
Thanks!
Would love to be added if there is room. @heidefordlab.bsky.social
Thank you!
Happy to start my migration to bluesky!! Excited to meet you all here and share our science.